Disgraced cyclist Lance Armstrong, who was stripped of his seven Tour de France titles for doping, is weighing whether to admit he used performance-enhancing drugs, The New York Times reported.
Armstrong has told associates and anti-doping officials he is considering admitting publicly that he used blood transfusions and banned drugs during his cycling career in an effort to restore his credibility so he can become a competitive athlete again, the newspaper reported.
The Times did not name its sources but cited "several people with direct knowledge of the situation."
The International Cycling Union (UCI) late last year effectively erased Armstrong from the cycling history books when it decided not to appeal sanctions imposed on the American by the United States Anti-Doping Agency (USADA).
A damning report by USADA concluded that Armstrong helped orchestrate the most sophisticated doping program in the history of sport. The report included hundreds of pages of eyewitness testimony, emails, financial records and laboratory analysis of blood samples.
Armstrong has vehemently denied ever having doped.
Tim Herman, a lawyer for Armstrong, told the Times he was not aware of any admission plans.
"I do not know about that. I suppose anything is possible, for sure. Right now, that's really not on the table," Herman was quoted as saying.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
